First Line Treatment of Adults with Ph+ ALL: Intermediate Analysis of the ALLPh2022 trial – Resonance

First Line Treatment of Adults with Ph+ ALL: Intermediate Analysis of the ALLPh2022 trial – Resonance

ALRCaN presents “First-Line Treatment of Adults with Ph+ ALL: Intermediate Analysis of the ALLPh2022 Trial” with Josep Maria Ribera

“Dear friends and colleagues,

We look forward to seeing you every Friday at 9 am ET to enjoy lively discussions on leukemia and supportive care topics.

Warm regards,

Scott Howard, Stacy Cooper, Archie Bleyer, Dan Douer, and the Resonance Team.”

  • Date: July 24, 2026
  • Time: 09:00 AM–10:00 AM ET (05:00 PM–06:00 PM AMT)
  • Presenter: Josep Maria Ribera
  • Organizer: Acute Leukemia Research and Care Network (ALRCaN)

This activity has been approved for AMA PRA Category 1 Credit™.

You can read more posts featuring Resonance on OncoDaily.

Medically reviewed Jul 21, 2026 by Mariam Khachatryan, MD